1/
Thought your Blue Wave was $BLUE related. No I do not fear govt price controls personally. I'm far more worried about tax policy and anti growth initiatives like the $4 increase Seattle just mandated which already led to 2 announced store closures
https://www.seattletimes.com/seattle-news/politics/seattle-city-council-approves-4-per-hour-mandatory-pay-boost-for-grocery-workers-during-covid-19-pandemic/ https://twitter.com/cbtadvisors/status/1362359725279633412
Thought your Blue Wave was $BLUE related. No I do not fear govt price controls personally. I'm far more worried about tax policy and anti growth initiatives like the $4 increase Seattle just mandated which already led to 2 announced store closures
https://www.seattletimes.com/seattle-news/politics/seattle-city-council-approves-4-per-hour-mandatory-pay-boost-for-grocery-workers-during-covid-19-pandemic/ https://twitter.com/cbtadvisors/status/1362359725279633412
2/
Price hikes in pharma have already moderated. We used to see double digit % increases every year. Pharma got the message and cut it to 4.8% in 2016 as Epipen fiasco was raging.
https://www.policymed.com/2017/05/drug-prices-are-growing-at-slowest-rate-in-years.html
Price hikes in pharma have already moderated. We used to see double digit % increases every year. Pharma got the message and cut it to 4.8% in 2016 as Epipen fiasco was raging.
https://www.policymed.com/2017/05/drug-prices-are-growing-at-slowest-rate-in-years.html
3/
2020 prices on generics were up too much over 6% while others were moderately lower around 3%. biopharmas like $NVS are spinning out generics and focusing on their pipeline - even #ARK fcst a return to 20+% topline growth from innovation in 5yrs https://www.goodrx.com/blog/july-drug-price-hikes-2020/
2020 prices on generics were up too much over 6% while others were moderately lower around 3%. biopharmas like $NVS are spinning out generics and focusing on their pipeline - even #ARK fcst a return to 20+% topline growth from innovation in 5yrs https://www.goodrx.com/blog/july-drug-price-hikes-2020/
4/
Price controls on gene therapy products are likely to be attacked as we have already seen with the few announced. Reality is cures are significantly cheaper than perpetual treatments/drugs to slow disease and moderate symptoms. Noisy yes. Bad outcomes unlikely
Price controls on gene therapy products are likely to be attacked as we have already seen with the few announced. Reality is cures are significantly cheaper than perpetual treatments/drugs to slow disease and moderate symptoms. Noisy yes. Bad outcomes unlikely